Bayer CropScience | GenomeWeb

Bayer CropScience

The two companies will use KeyGene's technology for the genetic analysis of field and vegetable crops.

A draft sequence of a diploid A cotton genome released yesterday will lay the groundwork for sequencing the tetraploid genome of widely cultivated cotton species.

NEW YORK (GenomeWeb) – Bayer CropScience today said that it is investing almost $1 billion in capital expenditures in the US between 2013 and 2016 to build up its R&D capabilities and expand its supply of crop protection brands.

NEW YORK (GenomeWeb) – Evogene today said that its collaboration with Bayer CropScience for wheat improvement has been amended to focus on novel genomic promoters from a prior focus on the discovery of additional genes and SNPs.

NEW YORK (GenomeWeb) – Bayer CropScience has licensed Persephone, a genome browsing application developed by Ceres, an agricultural biotechnology and seed company.

NEW YORK (GenomeWeb News) – Bayer CropScience and Targenomix have inked a research collaboration agreement to use systems biology approaches to investigate metabolic and regulatory networks in plants.

NEW YORK (GenomeWeb News) – Bayer CropScience said today it has inked two agreements with Cellectis plant sciences that extend a partnership focused on modifying and editing plant genes and genomes to improve crops.

NEW YORK (GenomeWeb News) – The International Wheat Genome Sequencing Consortium will receive roughly €1 million ($1.4 million) from Bayer CropScience over the next six months to complete a wheat genome sequencing and mapping project.

While chemical proteomics has traditionally focused on pharmaceutical work, several recent collaborations suggest that the field is establishing a foothold within agricultural research, as well.

NEW YORK (GenomeWeb News) – Bayer CropScience and Performance Plants have entered into a third licensing deal, this time aimed at improving wheat performance, they announced today.

Pages

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.